# A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix

> **NCT02482740** · PHASE2 · UNKNOWN · sponsor: **Buddhist Tzu Chi General Hospital** · enrollment: 44 (estimated)

## Conditions studied

- Uterine Cervical Neoplasms

## Interventions

- **DRUG:** Letrozole
- **DRUG:** tamoxifen

## Key facts

- **NCT ID:** NCT02482740
- **Lead sponsor:** Buddhist Tzu Chi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-05
- **Primary completion:** 2017-01
- **Final completion:** 2017-06
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2015-06-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02482740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02482740, "A Trial of Tamoxifen and Letrozole in Recurrent and Persistent Squamous Cell Carcinoma of the Cervix". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02482740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*